Concurrent Graves disease thyrotoxicosis and myasthenia gravis: the treatment of the former may dangerously reveal the latter

被引：8

作者：

Lakhal, K. ^{[1
]}

Blel, Y. ^{[2
]}

Fysekidis, M. ^{[3
]}

Mohammedi, K. ^{[3
]}

Bouadma, L. ^{[2
]}

机构：

[1] Hop Bichat Claude Bernard, F-75877 Paris 18, France

[2] Hop Bichat Claude Bernard, Serv Reanimat Med & Maladies, F-75877 Paris 18, France

[3] Hop Bichat Claude Bernard, Serv Endocrinol, F-75877 Paris 18, France

来源：

ANAESTHESIA | 2008年 / 63卷 / 08期

关键词：

D O I：

10.1111/j.1365-2044.2008.05496.x

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Autoimmune thyroxicosis and myasthenia gravis are often associated. In both diseases, clinical features may include neuromuscular weakness, making their distinction challenging. We report a patient with known Graves disease who presented with generalised fatigue, initially attributed solely to thyrotoxicosis, and who experienced severe respiratory failure linked to associated myasthenia gravis that was unmasked by medication used in the perioperative management of his thyroxicosis. Anaesthetists should always consider myasthenia gravis in cases of hyperthyroidism presenting with neuromuscular features.

引用

页码：876 / 879

页数：4

共 24 条

[1] Clinical predictors of steroid-induced exacerbation in myasthenia gravis [J].